[1]
“Levosimendan off-label successfully used in two patients with exacerbated COPD and severe bronchospasm: a case series focusing on an explorative review of the current literature”, Adv Anest Pain Med, vol. 1, no. 1, Nov. 2023, doi: 10.4081/amsa.2023.36.